创新链/学科链/研发链/产业链

新药研发前沿动态 / 医药领域趋势进展

刁仁昌, 卢旻, 陈翀, 陈晨, 丁雪清. 国家谈判药品落地南京的实践与思考[J]. 药学进展, 2021, 45(10): 769-774.
引用本文: 刁仁昌, 卢旻, 陈翀, 陈晨, 丁雪清. 国家谈判药品落地南京的实践与思考[J]. 药学进展, 2021, 45(10): 769-774.
DIAO Renchang, LU Min, CHEN Chong, CHEN Chen, DING Xueqing. Reflections on National Negotiated Drugs in Nanjing[J]. Progress in Pharmaceutical Sciences, 2021, 45(10): 769-774.
Citation: DIAO Renchang, LU Min, CHEN Chong, CHEN Chen, DING Xueqing. Reflections on National Negotiated Drugs in Nanjing[J]. Progress in Pharmaceutical Sciences, 2021, 45(10): 769-774.

国家谈判药品落地南京的实践与思考

Reflections on National Negotiated Drugs in Nanjing

  • 摘要: 国家谈判药品落地,事关广大参保患者的切身利益和人民群众的健康福祉。通过整理南京市国家谈判药品的落地情况,分析和总结了南京市在国家谈判药品落地实施过程中的实践经验,并提出思考与建议,以期为促进国家谈判药品的落地工作提供参考。

     

    Abstract: The implementation of policy for national negotiated drugs concerns the vital interests of insured patients and the health and well-being of the people. This paper reviews the current situation of the national negotiated drugs in Nanjing, and summarizes Nanjing's practical experience in implementing the policies and regulations concerning the national negotiated drugs, with some reflections and suggestions in the hope of providing some reference for promoting the implementation of this policy.

     

/

返回文章
返回